
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Rainforest Clove (Syzygium aromaticum) contains 70-90% eugenol, which inhibits cyclooxygenase and lipoxygenase pathways to reduce inflammation and exhibits broad-spectrum antimicrobial activity. The compound also modulates glucose metabolism through enhanced insulin sensitivity and stimulates digestive enzyme secretion.

Reported Benefits (Provisional)
Origin & History

Rainforest Clove (Syzygium aromaticum) is the aromatic flower bud of a tree native to the tropical rainforests of Southeast Asia, particularly Indonesia, with related species found in South America and West Africa. This potent spice is celebrated for its rich concentration of bioactive compounds, especially eugenol. It offers significant functional benefits for immune resilience, digestive health, and metabolic balance.
Research Narrative (Provisional)
Modern scientific research, including in vitro and animal studies, supports clove's potent antioxidant, anti-inflammatory, and antimicrobial properties, largely attributed to its eugenol content. Studies also indicate its potential for supporting digestive health and metabolic balance. While promising, more human clinical trials are needed to fully establish its efficacy across all traditional applications.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Terpenes (Eugenol, Caryophyllene, Humulene), Flavonoids (Quercetin, Kaempferol), Polyphenols (Ellagic acid, Gallic acid, Catechins), Tannins - Vitamins: Vitamin C, Vitamin K - Minerals: Manganese, Magnesium, Potassium, Iron - Macronutrients: Dietary Fiber - Enzymes: Digestive enzymes (trace amounts)
Reported Mechanism (Provisional)
Eugenol, the primary bioactive compound comprising 70-90% of clove's volatile oil, inhibits cyclooxygenase (COX) and lipoxygenase enzymes, reducing prostaglandin E2 and leukotriene synthesis. The compound disrupts bacterial cell membranes through lipid peroxidation and demonstrates calcium channel blocking activity. Eugenol also enhances insulin receptor sensitivity and stimulates pancreatic enzyme secretion via cholinergic pathways.
Clinical Narrative (Provisional)
Current evidence is primarily limited to in vitro and animal studies, with few human clinical trials available. Laboratory studies demonstrate significant antimicrobial activity against Staphylococcus aureus, E. coli, and Candida species at concentrations of 0.1-2%. Animal studies show 40-60% reduction in inflammatory markers and improved glucose tolerance, but sample sizes remain small (typically 10-20 subjects per group). More robust human clinical trials are needed to establish therapeutic dosing and clinical efficacy.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







